Mainz Biomed N.V (MYNZ) Shares Outstanding (Diluted Average): 2020-2025
- Mainz Biomed N.V's Shares Outstanding (Diluted Average) rose 462.76% to $3.1 million in Q2 2025 from the same period last year, while for Jun 2025 it was $3.1 million, marking a year-over-year increase of 462.76%. This contributed to the annual value of $968,234 for FY2024, which is 138.45% up from last year.
- Latest data reveals that Mainz Biomed N.V reported Shares Outstanding (Diluted Average) of $3.1 million as of Q2 2025, which was up 224.76% from $968,234 recorded in Q4 2024.
- Over the past 5 years, Mainz Biomed N.V's Shares Outstanding (Diluted Average) peaked at $14.2 million during Q4 2022, and registered a low of $406,058 during Q4 2023.
- Moreover, its 3-year median value for Shares Outstanding (Diluted Average) was $763,492 (2024), whereas its average is $1.3 million.
- In the last 5 years, Mainz Biomed N.V's Shares Outstanding (Diluted Average) slumped by 97.13% in 2023 and then surged by 462.76% in 2025.
- Quarterly analysis of 5 years shows Mainz Biomed N.V's Shares Outstanding (Diluted Average) stood at $7.2 million in 2021, then surged by 96.33% to $14.2 million in 2022, then crashed by 97.13% to $406,058 in 2023, then spiked by 138.45% to $968,234 in 2024, then surged by 462.76% to $3.1 million in 2025.
- Its Shares Outstanding (Diluted Average) was $3.1 million in Q2 2025, compared to $968,234 in Q4 2024 and $558,751 in Q2 2024.